Public Release: 

Champalimaud Award recognizes revolutionary treatment of devastating blindness diseases

The award, the largest in the world in the area of eyesight, worth 1 million euros, goes to 7 researchers

JLM&A, SA

September 10, 2014 - Lisbon, Portugal - The 2014 António Champalimaud Vision Award is given to seven researchers for the development of Anti-Angiogenic Therapy for Retinal Disease.

The conditions it helps treat, especially age-related macular degeneration and diabetic retinopathy, are the most important causes of blindness in several countries, and their prevalence is growing with the increasing age of the population and the global epidemic of diabetes linked to dietary habits and obesity.

In the 1980s, Napoleone Ferrara began his work that ultimately isolated and cloned a protein responsible for vascular endothelial growth, VEGF ("Vascular Endothelial Growth Factor"). Ferrara went on to develop a molecule to block VEGF's action. Many investigators, including those with whom Ferrara shares this prize, Joan Miller, Evangelos Gragoudas, Patricia D'Amore, Anthony Adamis, George King and Lloyd Paul Aiello, working independently and together, often with Ferrara, went on to demonstrate the important role that VEGF played in ocular retinal disease, and how anti-VEGF agents could block its effect. For the first time, a pharmacologic intervention that significantly improves the vision of patients affected by these often devastating retinal conditions is now available.

The work of this year's awardees covers the entire research process, from the identification of the molecule, to the elucidation of its role in retinal-vascular disease in animals and humans, to the experimental evaluation of an inhibitor and its final application in the treatment of affected patients.

The clinical value of anti-VEGF therapy has been well established through a large number of clinical trials in patients with neovascular age-related macular degeneration, diabetic macular edema and retinal vein occlusions, offering the first real hope to millions of affected individuals around the world.

The 2014 António Champalimaud Vision awardees were honored on a ceremony held at the Champalimaud Centre for the Unknown in Lisbon, Portugal. Presiding at the ceremony was Aníbal António Cavaco Silva, President of the Portuguese Republic.

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.